Table 1.
Patient and tumour characteristics at time of primary thermal ablation (TA)
| Demographics | Patients (N = 176) |
|---|---|
| Median age (IQR; range) | 64·5 years; (58·0–70·8; 12-90) |
| Male sex, N (%) | 142 (80·7%) |
| Cirrhosis | |
| Yes | 159 (90·3%) |
| Child–Pugh class | |
| A | 151 (89·3%) |
| B | 18 (10·7%) |
| Primary Underlying Liver Disease | |
| (N)ASH | 94 (53·4%) |
| Viral | 53 (30·1%) |
| Metabolic | 6 (3·4%) |
| Cholestatic | 5 (2·8%) |
| Cryptogenic cirrhosis | 8 (4·5%) |
| Other/unknown | 10 (5·7%) |
| Tumour characteristics | |
| Median diameter of largest tumour (IQR; range) | 2·7 cm (2·0–3·3; 0.5-8.0) |
| Number of tumours | |
| 1 | 126 (71·6%) |
| 2 | 42 (23·9%) |
| 3 | 6 (3·4%) |
| 4 | 2 (1·1%) |
| BCLC stage | |
| Very early | 22 (12·5%) |
| Early | 136 (77·3%) |
| Intermediate | 18 (10·2%) |
| Type of TA | |
| RFA | 72 (40.9%) |
| MWA | 104 (59.1%) |
| AFP level | |
| Median (IQR; range) | 7·8 (3·6–27·0; 1–54,000) |